MiNK Therapeutics, Inc. (INKT) Free cash flow 2020–2023
MiNK Therapeutics, Inc. (INKT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$15.8MFY2023 · since FY2020: -$8.4M → -$15.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$15.8M | +17.2% |
| FY2022 | -$19.1M | -46.2% |
| FY2021 | -$13.1M | -55.1% |
| FY2020 | -$8.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice